Literature DB >> 154626

Huntington disease: clinical care and evaluation.

I Shoulson, S Fahn.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 154626     DOI： 10.1212/wnl.29.1.1

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  170 in total

1.  Cognitive procedural learning in patients with fronto-striatal lesions.

Authors:  Klaus Schmidtke; Hendrik Manner; Robert Kaufmann; Heike Schmolck
Journal:  Learn Mem       Date:  2002 Nov-Dec       Impact factor: 2.460

2.  Challenges assessing clinical endpoints in early Huntington disease.

Authors:  Jane S Paulsen; Chiachi Wang; Kevin Duff; Roger Barker; Martha Nance; Leigh Beglinger; David Moser; Janet K Williams; Sheila Simpson; Douglas Langbehn; Daniel P van Kammen
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

3.  New measures to capture end of life concerns in Huntington disease: Meaning and Purpose and Concern with Death and Dying from HDQLIFE (a patient-reported outcomes measurement system).

Authors:  N E Carlozzi; N R Downing; M K McCormack; S G Schilling; J S Perlmutter; E A Hahn; J S Lai; S Frank; K A Quaid; J S Paulsen; D Cella; S M Goodnight; J A Miner; M A Nance
Journal:  Qual Life Res       Date:  2016-07-08       Impact factor: 4.147

4.  Visual processing disorders in patients with Huntington's disease and asymptomatic carriers.

Authors:  E Gómez-Tortosa; A del Barrio; T Barroso; P J García Ruiz
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

5.  Qualitative and quantitative study of the growth and cell surface properties of Huntington's disease fibroblasts and age-matched controls. Lack of significant differences.

Authors:  J J Cassiman; J Verlinden; R F Vlietinck; J Bellemans; F Van Leuven; J Deroover; F Baro; H Van den Berghe
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

6.  Understanding the need for assistance with survey completion in people with Huntington disease.

Authors:  Elizabeth A Hahn; Nancy R Downing; Julie C Stout; Jane S Paulsen; Becky Ready; Siera Goodnight; Jin-Shei Lai; Jennifer A Miner; Noelle E Carlozzi
Journal:  Qual Life Res       Date:  2017-12-06       Impact factor: 4.147

7.  Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease.

Authors:  N R Swerdlow; J Paulsen; D L Braff; N Butters; M A Geyer; M R Swenson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

8.  HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD).

Authors:  N E Carlozzi; S G Schilling; J-S Lai; J S Paulsen; E A Hahn; J S Perlmutter; C A Ross; N R Downing; A L Kratz; M K McCormack; M A Nance; K A Quaid; J C Stout; R C Gershon; R E Ready; J A Miner; S K Barton; S L Perlman; S M Rao; S Frank; I Shoulson; H Marin; M D Geschwind; P Dayalu; S M Goodnight; D Cella
Journal:  Qual Life Res       Date:  2016-08-13       Impact factor: 4.147

9.  Oligoclonal "fingerprint" of CSF IgG in multiple sclerosis patients is not modified following intrathecal administration of natural beta-interferon.

Authors:  C Confavreux; C Chapuis-Cellier; P Arnaud; O Robert; G Aimard; M Devic
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

10.  Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?

Authors:  N E Carlozzi; S Schilling; A L Kratz; J S Paulsen; S Frank; J C Stout
Journal:  Qual Life Res       Date:  2018-06-16       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.